Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional Not Pharmacological Study to Investigate the Role of ADA in Multiple Sclerosis PatientsTreated With an Immune-Reconstitution Therapy (2-CdA)

NCT04121065 is registered in ClinicalTrials.gov with Neuromed IRCCS as lead sponsor.

NCT NCT04121065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04121065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional Not Pharmacological Study to Investigate the Role of ADA in Multiple Sclerosis PatientsTreated With an Immune-Reconstitution Therapy (2-CdA)
Lead sponsor
Neuromed IRCCS
Phase
Observational
Overall status
Unknown status
Start date
September 7, 2020
Completion date
June 30, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing multiple sclerosis